Check Out What Whales Are Doing With REGN
Portfolio Pulse from Benzinga Insights
A significant bearish stance has been taken on Regeneron Pharmaceuticals (NASDAQ:REGN) by a large investor, as observed in the options history. The overall sentiment of these big-money traders is 90% bearish and 10% bullish. The whales have been targeting a price range from $770.0 to $860.0 for Regeneron Pharmaceuticals over the last 3 months. Wells Fargo, Truist Securities, Canaccord Genuity, and Barclays have given price targets of $980, $1045, $992, and $900 respectively.
August 25, 2023 | 6:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
A large investor has taken a bearish stance on Regeneron Pharmaceuticals. The overall sentiment of big-money traders is 90% bearish. Analysts have given various price targets.
The bearish stance taken by a large investor and the overall sentiment of big-money traders being 90% bearish indicates a potential decrease in the stock price of Regeneron Pharmaceuticals. The various price targets given by analysts also play a role in influencing the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100